NCT01733979

Efficacy and Safety of Heme-Iron Polypeptide on Improvement of Anemia

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (actual)
• Sponsor: Chonbuk National University Hospital · Academic / Other
• Sex: All
• Age: 19 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The investigators performed a 4-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Heme-Iron Polypeptide on Improvement of Anemia. The investigators measured Improvement of Anemia parameters , including hemoglobin, transferrin saturation, serum iron, and ferritin, and monitored their blood pressure.

Conditions

• Anemia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Heme-Iron Polypeptide	Heme-Iron Polypeptide (1g/day)
DIETARY_SUPPLEMENT	Placebo	Placebo (1g/day)
DIETARY_SUPPLEMENT	Heme-Iron	Heme-Iron (1g/day)
DIETARY_SUPPLEMENT	Organic Iron	Organic Iron (1g/day)

Timeline

• Start date: 2012-02-07
• Primary completion: 2012-11-14
• Completion: 2012-11-14
• First posted: 2012-11-27
• Last updated: 2019-08-26

Locations

1 site across 1 country: South Korea